Actinium Pharmaceuticals, Inc. (ATNM)
1.41
+0.01
(+0.71%)
USD |
NYAM |
Dec 09, 12:38
Actinium Pharmaceuticals EPS Diluted (Quarterly): -0.1645 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | -1.268 |
| Apyx Medical Corp. | -0.0487 |
| AbbVie, Inc. | 0.0993 |
| Karyopharm Therapeutics, Inc. | -3.821 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.131M |
| Revenue (Quarterly) | 0.09M |
| Total Expenses (Quarterly) | 5.221M |
| Enterprise Value | -8.574M |
| Gross Profit Margin (Quarterly) | -128.9% |
| Profit Margin (Quarterly) | -5.70K% |
| Earnings Yield | -78.66% |
| Normalized Earnings Yield | -78.66 |